1. Li, Jingyi, Chen, Ziyu, Jin, Mingming, Zhao, Weiming, Lu, Changlian. 2024. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. In Cellular signalling, 124, 111468. doi:10.1016/j.cellsig.2024.111468. https://pubmed.ncbi.nlm.nih.gov/39395526/
2. Martinez, Rafael S, Salji, Mark J, Rushworth, Linda, Blomme, Arnaud, Leung, Hing Y. 2021. SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer. In Cancer research, 81, 3664-3678. doi:10.1158/0008-5472.CAN-20-3694. https://pubmed.ncbi.nlm.nih.gov/33985973/
3. Wang, Shunying, Li, Li, Wang, Wenming. 2023. Knockdown of Slfn5 alleviates lipopolysaccharide-induced pneumonia by regulating Janus kinase/signal transduction and activator of transcription pathway. In Journal of thoracic disease, 15, 6708-6720. doi:10.21037/jtd-23-889. https://pubmed.ncbi.nlm.nih.gov/38249884/
4. Wu, Yueh-Jung, Chiao, Chung-Chieh, Chuang, Po-Kai, Wang, Chih-Yang, Lee, Yung-Kuo. 2024. Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity. In International journal of medical sciences, 21, 2348-2364. doi:10.7150/ijms.97975. https://pubmed.ncbi.nlm.nih.gov/39310264/
5. Xu, Qiao Ping, Deng, Kui, Zhang, Zhen, Shang, Hongkai. 2023. SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer. In Journal of ovarian research, 16, 33. doi:10.1186/s13048-023-01103-7. https://pubmed.ncbi.nlm.nih.gov/36747204/
智鼠故事 
